The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cerebral Infarction

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cerebral Infarction


Psychiatry related information on Cerebral Infarction


High impact information on Cerebral Infarction


Chemical compound and disease context of Cerebral Infarction

  • Among the patients with no history of stroke, cerebral infarction occurred in 19 of the 265 patients in the placebo group during an average follow-up of 1.7 years (4.3 percent per year) and in 4 of the 260 patients in the warfarin group during an average follow-up of 1.8 years (0.9 percent per year) [1].
  • Letter: Glycerol v. dexamethasone in acute cerebral infarction [15].
  • A novel variant of antithrombin III (AT III) that lacks affinity for heparin was found in a 33-year-old man who suffered from recurrent cerebral infarction [16].
  • We studied the relation of serum glucose level measured in the first 12 hours of symptoms to the clinical findings, results of computed tomography (CT), and patterns of cerebral metabolism in 39 patients who had acute ischemic cerebral infarction [17].
  • At any period of this neonatal model, brain lactate levels did not exceed the toxic level, which is postulated to be responsible for cerebral infarction in adult ischemic models [18].

Biological context of Cerebral Infarction


Anatomical context of Cerebral Infarction


Gene context of Cerebral Infarction


Analytical, diagnostic and therapeutic context of Cerebral Infarction


  1. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Ezekowitz, M.D., Bridgers, S.L., James, K.E., Carliner, N.H., Colling, C.L., Gornick, C.C., Krause-Steinrauf, H., Kurtzke, J.F., Nazarian, S.M., Radford, M.J. N. Engl. J. Med. (1992) [Pubmed]
  2. Intraoperative cerebral infarction after desmopressin administration in infant with end-stage renal disease. Grunwald, Z., Sather, S.D. Lancet (1995) [Pubmed]
  3. Activated protein C resistance in cases of cerebral infarction. Forsyth, P.D., Dolan, G. Lancet (1995) [Pubmed]
  4. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Castillo, J., Moro, M.A., Blanco, M., Leira, R., Serena, J., Lizasoain, I., Dávalos, A. Ann. Neurol. (2003) [Pubmed]
  5. Intracerebral hemorrhage versus infarction: stroke severity, risk factors, and prognosis. Jørgensen, H.S., Nakayama, H., Raaschou, H.O., Olsen, T.S. Ann. Neurol. (1995) [Pubmed]
  6. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. Peress, N.S., Perillo, E. J. Neuropathol. Exp. Neurol. (1995) [Pubmed]
  7. When do strokes cause dementia? Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Foster, N.L., Hickenbottom, S.L. Arch. Neurol. (1999) [Pubmed]
  8. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. DeCarli, C., Miller, B.L., Swan, G.E., Reed, T., Wolf, P.A., Carmelli, D. Arch. Neurol. (2001) [Pubmed]
  9. Inosine reduces ischemic brain injury in rats. Shen, H., Chen, G.J., Harvey, B.K., Bickford, P.C., Wang, Y. Stroke (2005) [Pubmed]
  10. Demonstration of ganglioside GD3 in human reactive astrocytes. Kawai, K., Watarai, S., Takahashi, H., Ishizu, H., Fukai, K., Tanabe, Y., Yokota, O., Kuroda, S. Psychiatry and clinical neurosciences. (1999) [Pubmed]
  11. Prostacyclin in cerebral infarction. Martin, J.F., Hamdy, N., Nicholl, J., Lewtas, N., Bergvall, U., Owen, P., Syder, D., Middlebrook, A. N. Engl. J. Med. (1985) [Pubmed]
  12. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. Laufs, U., Endres, M., Stagliano, N., Amin-Hanjani, S., Chui, D.S., Yang, S.X., Simoncini, T., Yamada, M., Rabkin, E., Allen, P.G., Huang, P.L., Böhm, M., Schoen, F.J., Moskowitz, M.A., Liao, J.K. J. Clin. Invest. (2000) [Pubmed]
  13. Multiple subcortical infarction: CADASIL in context. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. Broe, G.A., Bennett, H.P. Lancet (1995) [Pubmed]
  14. Cerebral infarction, cerebral haemorrhage, and ABO blood-groups. Larsen, S., Anthonisen, B., Marquardsen, J. Lancet (1977) [Pubmed]
  15. Letter: Glycerol v. dexamethasone in acute cerebral infarction. Silverstone, P.I., McIntosh, A.S. Lancet (1975) [Pubmed]
  16. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis. Okajima, K., Abe, H., Maeda, S., Motomura, M., Tsujihata, M., Nagataki, S., Okabe, H., Takatsuki, K. Blood (1993) [Pubmed]
  17. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Kushner, M., Nencini, P., Reivich, M., Rango, M., Jamieson, D., Fazekas, F., Zimmerman, R., Chawluk, J., Alavi, A., Alves, W. Ann. Neurol. (1990) [Pubmed]
  18. Posthypoxic glucose supplement reduces hypoxic-ischemic brain damage in the neonatal rat. Hattori, H., Wasterlain, C.G. Ann. Neurol. (1990) [Pubmed]
  19. Circulatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction. Meyer, J.S., Itoh, Y., Okamoto, S., Welch, K.M., Mathew, N.T., Ott, E.O., Sakaki, S., Miyakawa, Y., Chabi, E., Ericsson, A.D. Circulation (1975) [Pubmed]
  20. Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Joseph, R., D'Andrea, G., Oster, S.B., Welch, K.M. Stroke (1989) [Pubmed]
  21. Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland. Salonen, J.T., Puska, P., Tuomilehto, J., Homan, K. Stroke (1982) [Pubmed]
  22. Effects of agents used in the pharmacotherapy of cerebrovascular disease on the oxygen consumption of isolated cerebral mitochondria. Nowicki, J.P., MacKenzie, E.T., Spinnewyn, B. J. Cereb. Blood Flow Metab. (1982) [Pubmed]
  23. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Couderc, R., Mahieux, F., Bailleul, S., Fenelon, G., Mary, R., Fermanian, J. Stroke (1993) [Pubmed]
  24. Molecular features of immunoreactive myelin basic protein in cerebrospinal fluid of persons with multiple slcerosis. Bashir, R.M., Whitaker, J.N. Ann. Neurol. (1980) [Pubmed]
  25. Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Griffey, R.H., Brown, M.S., Bankhurst, A.D., Sibbitt, R.R., Sibbitt, W.L. Arthritis Rheum. (1990) [Pubmed]
  26. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. De Keyser, J., Wilczak, N., Leta, R., Streetland, C. Neurology (1999) [Pubmed]
  27. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Xia, C.F., Yin, H., Yao, Y.Y., Borlongan, C.V., Chao, L., Chao, J. Hum. Gene Ther. (2006) [Pubmed]
  28. Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. Umemura, K., Wada, K., Uematsu, T., Nakashima, M. Stroke (1993) [Pubmed]
  29. Increased plasma endothelin-1 in acute ischemic stroke. Ziv, I., Fleminger, G., Djaldetti, R., Achiron, A., Melamed, E., Sokolovsky, M. Stroke (1992) [Pubmed]
  30. Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Harvey, B.K., Hoffer, B.J., Wang, Y. Pharmacol. Ther. (2005) [Pubmed]
  31. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Loddick, S.A., Rothwell, N.J. J. Cereb. Blood Flow Metab. (1996) [Pubmed]
  32. Role of cyclooxygenase-2 in the development of bladder overactivity after cerebral infarction in the rat. Yotsuyanagi, S., Yokoyama, O., Komatsu, K., Kodama, K., Nagasaka, Y., Namiki, M. J. Urol. (2005) [Pubmed]
  33. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Kubo, M., Hata, J., Ninomiya, T., Matsuda, K., Yonemoto, K., Nakano, T., Matsushita, T., Yamazaki, K., Ohnishi, Y., Saito, S., Kitazono, T., Ibayashi, S., Sueishi, K., Iida, M., Nakamura, Y., Kiyohara, Y. Nat. Genet. (2007) [Pubmed]
  34. Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Fletcher, A.P., Alkjaersig, N., Davies, A., Lewis, M., Brooks, J., Hardin, W., Landau, W., Raichle, M.E. Stroke (1976) [Pubmed]
  35. CT enhancement after prolonged high-dose contrast infusion in the early stage of cerebral infarction. Ito, U., Tomita, H., Kito, K., Ueki, Y., Inaba, Y. Stroke (1986) [Pubmed]
  36. Hemorrhagic complications of thrombolytic therapy in experimental stroke. Slivka, A., Pulsinelli, W. Stroke (1987) [Pubmed]
  37. Duration of glutamate release after acute ischemic stroke. Dávalos, A., Castillo, J., Serena, J., Noya, M. Stroke (1997) [Pubmed]
  38. Free protein S deficiency in acute ischemic stroke. A case-control study. Mayer, S.A., Sacco, R.L., Hurlet-Jensen, A., Shi, T., Mohr, J.P. Stroke (1993) [Pubmed]
WikiGenes - Universities